360 related articles for article (PubMed ID: 15671494)
1. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
[TBL] [Abstract][Full Text] [Related]
3. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Choi YG; Lim S
J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
[TBL] [Abstract][Full Text] [Related]
4. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.
Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R
J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of antibodies for evaluating the biological significance of AGEs.
Nagai R; Fujiwara Y; Mera K; Motomura K; Iwao Y; Tsurushima K; Nagai M; Takeo K; Yoshitomi M; Otagiri M; Ikeda T
Ann N Y Acad Sci; 2008 Apr; 1126():38-41. PubMed ID: 18079488
[TBL] [Abstract][Full Text] [Related]
6. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
7. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
Ikeda K; Higashi T; Sano H; Jinnouchi Y; Yoshida M; Araki T; Ueda S; Horiuchi S
Biochemistry; 1996 Jun; 35(24):8075-83. PubMed ID: 8672512
[TBL] [Abstract][Full Text] [Related]
8. Generation of antibodies to Di- and trichloroacetylated proteins and immunochemical detection of protein adducts in rats treated with perchloroethene.
Pähler A; Birner G; Parker J; Dekant W
Chem Res Toxicol; 1998 Sep; 11(9):995-1004. PubMed ID: 9760273
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhibitor compounds on Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) formation in model foods.
Srey C; Hull GL; Connolly L; Elliott CT; del Castillo MD; Ames JM
J Agric Food Chem; 2010 Nov; 58(22):12036-41. PubMed ID: 21043504
[TBL] [Abstract][Full Text] [Related]
10. Rapid and simple method for determination of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in urine using gas chromatography/mass spectrometry.
Petrovic R; Futas J; Chandoga J; Jakus V
Biomed Chromatogr; 2005 Nov; 19(9):649-54. PubMed ID: 15803449
[TBL] [Abstract][Full Text] [Related]
11. An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages.
Mera K; Nagai R; Takeo K; Izumi M; Maruyama T; Otagiri M
Biochem Biophys Res Commun; 2011 Apr; 407(2):420-5. PubMed ID: 21402053
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical and mass spectrometric analysis of Nε-(carboxymethyl)lysine content of AGE-BSA systems prepared with and without selected antiglycation agents.
Srey C; Haughey SA; Connolly L; del Castillo MD; Ames JM; Elliott CT
J Agric Food Chem; 2010 Nov; 58(22):11955-61. PubMed ID: 20979353
[TBL] [Abstract][Full Text] [Related]
13. Site specificity of glycation and carboxymethylation of bovine serum albumin by fructose.
Hinton DJ; Ames JM
Amino Acids; 2006 Jun; 30(4):425-34. PubMed ID: 16583308
[TBL] [Abstract][Full Text] [Related]
14. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
15. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis.
Schmitt S; Linder M; Ständker L; Hammes HP; Preissner KT
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):26-34. PubMed ID: 17926233
[TBL] [Abstract][Full Text] [Related]
16. Isotope dilution ESI-LC-MS/MS for quantification of free and total Nε-(1-Carboxymethyl)-L-Lysine and free Nε-(1-Carboxyethyl)-L-Lysine: comparison of total Nε-(1-Carboxymethyl)-L-Lysine levels measured with new method to ELISA assay in gruel samples.
Tareke E; Forslund A; Lindh CH; Fahlgren C; Östman E
Food Chem; 2013 Dec; 141(4):4253-9. PubMed ID: 23993613
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Determination of N
Gong RZ; Wang YH; Wang YF; Chen B; Gao K; Sun YS
Molecules; 2018 Dec; 23(12):. PubMed ID: 30558131
[TBL] [Abstract][Full Text] [Related]
18. Chemical modification of proteins by methylglyoxal.
Degenhardt TP; Thorpe SR; Baynes JW
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
Wang X; Jia X; Chang T; Desai K; Wu L
J Hypertens; 2008 Apr; 26(4):765-72. PubMed ID: 18327087
[TBL] [Abstract][Full Text] [Related]
20. Identification of N epsilon-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes.
Nagai R; Araki T; Hayashi CM; Hayase F; Horiuchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):75-84. PubMed ID: 12668073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
